follow us

follow us

Speakers

  1. Pharmacovigilance World 2024
  2. Speakers
  3. Anna Adams

Anna Adams


Senior Director, Business Excellence & Project Management - Daiichi Sankyo



Anna is the Senior Director for Business Excellence and Project Management in the Clinical Safety and Pharmacovigilance Unit at Daiichi Sankyo, where she leads global strategic planning and improvement initiatives. Before joining Daiichi Sankyo earlier this year, Anna was Head of Performance and Compliance for pharmacovigilance submissions at Kenvue, the former Consumer Health arm of Johnson & Johnson. She also lead some of the initiatives to establish the new pharmacovigilance system in the new Kenvue organisation. Anna has a unique and pragmatic perspective on PV process excellence gained during her time serving as a Senior Pharmacovigilance Inspector at the MHRA. Here she conducted many inspections of organisations with diverse pharmacovigilance systems and developed inspection strategy. Anna holds a PhD in Peptide Chemistry and Molecular Biology from University College London and a Master’s degree in Chemistry from the University of Southampton.



Anna Adams

Sessions


  • Thursday - September 12, 2024 - 12:15

    From Inspector to Industry: Ensuring PV Process Excellence through Collaboration

    • Introducing PV excellence to through effective change management and collaboration
    • Skills and pointers to successfully introduce and navigate process changes in any part of the PV system
    • How organisations can keep pace with changing PV landscape and technologies
      Presentation

  • Thursday - September 12, 2024 - 15:50

    Panel Discussion – Unleashing the Potential: Digital Transformation in Pharmacovigilance – Opportunities, Challenges and Future Directions

    • How artificial intelligence and machine learning are reshaping pharmacovigilance by enhancing signal detection, automating adverse event processing, and predicting potential risks.
    • The utilization of real-world data from sources such as electronic health records, social media, and wearables for more comprehensive and timely adverse event monitoring.
    • The role of digital technologies in improving patient engagement and reporting of adverse events, and the impact of patient-generated data on pharmacovigilance efforts.
    • Addressing the challenges related to data privacy, security, and compliance with evolving regulations in the context of digital transformation in pharmacovigilance.
    • The emerging trends, opportunities, and best practices in the ongoing digital transformation journey within the field of pharmacovigilance.

 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now